Tag: Chemotherapy
ctDNA-Based Detection of Residual Disease Prognostic for Resected CRC
ctDNA-based detection of molecular residual disease in response to adjuvant chemotherapy prognostic of outcomes
Chemoradiation With SABR Boost Safe, Effective for Advanced Lung Cancer
Increased radiation with SABR boost seems to enhance local control but with reduced overall survival at highest dose
SABCS: Neoadjuvant Chemo Can Let Breast Cancer Patients Skip Nodal RT
Skipping adjuvant regional nodal irradiation does not increase risk for recurrence or death after neoadjuvant chemo before breast-conserving surgery
Mortality Higher for Black Patients Receiving Neoadjuvant Chemo for Breast Cancer
Black patients have increased mortality in refractory, sensitive disease; Asians have lower risk in refractory, sensitive, very sensitive disease
Osimertinib + Chemo Improves Progression-Free Survival in Advanced NSCLC
Greater incidence of grade 3 or higher adverse events from any cause seen in combination group versus monotherapy
Pembrolizumab + Standard Chemotherapy Beneficial in Mesothelioma
Improvement in overall survival seen for patients receiving cisplatin or carboplatin with pemetrexed
Vitamin D Insufficiency Linked to Paclitaxel-Induced Neuropathy
Pretreatment vitamin D insufficiency linked to increased incidence of grade ≥3 chemotherapy-induced peripheral neuropathy
ESMO: Pembrolizumab + Chemo, Trastuzumab Beneficial in Gastroesophageal Cancer
Improvement seen in progression-free survival with add-on pembrolizumab in gastroesophageal junction adenocarcinoma
NCCN: Cancer Centers Still Experiencing Shortages of Chemo Drugs
Overall, 72 and 59 percent of 26 cancer centers reported shortages in carboplatin and cisplatin
Gemcitabine, Cisplatin, Nivolumab Facilitate Bladder Sparing
Clinical complete response of 43 percent seen for those with muscle-invasive bladder cancer receiving neoadjuvant gemcitabine, cisplatin, plus nivolumab
